Market Research Logo

Global Allergic Rhinitis Drugs Market 2016-2020

Global Allergic Rhinitis Drugs Market 2016-2020

About Allergic Rhinitis Drugs

Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction causes mast cells to release and synthesize chemicals, causing inflammation of the surrounding tissues. Typical symptoms include rhinorrhea, nasal itching, sneezing, and nasal congestion. Extranasal symptoms such as allergic conjunctivitis, itchy ears and palate, and asthma may also occur. Allergic rhinitis is treated using medications such as antihistamines, intranasal corticosteroids, or immunotherapies. Alternative forms of treatment are also employed in certain cases.

Technavio’s analysts forecast the global allergic rhinitis market to grow at a CAGR of 0.95% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global allergic rhinitis drugs market for the period 2016-2020. To calculate the market size, it considers revenue generated from the sales of prescription and off-label drugs used to treat allergic rhinitis.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • Europe
Technavio's report, Global Allergic Rhinitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AstraZeneca
  • GlaxoSmithKline
  • Meda Pharmaceuticals
  • Merck
  • Sanofi
  • UCB
Other prominent vendors
  • Adamis Pharmaceuticals
  • Alcon
  • Alergo Pharma
  • ALK-Abelló
  • Allergy Therapeutics
  • Almirall
  • Ampio
  • Anergis
  • Apotex
  • Ares Life Sciences
  • Array BioPharma
  • Aspen Pharmacare
  • Atopix Therapeutics
  • Barr Laboratories
  • Belcher Pharmaceuticals
  • Circassia Pharmaceuticals
  • Dainippon Sumitomo
  • DBV Technologies
  • Dr Reddy's Laboratories
  • Eddingpharm
  • Genentech
  • Greer Laboratories
  • Hanmi Pharmaceuticals
  • Hisamitsu Pharmaceutical
  • Intas Pharmaceuticals
  • Kyowa Hakko
  • Lupin Pharmaceuticals
  • Mitsubishi Tanabe Pharma
  • Mylan
  • Nektar Therapeutics
  • Novartis
  • Nuvo Research
  • Nycomed
  • Omega Pharma
  • Ono Pharmaceuticals
  • Pfizer
  • Revance Therapeutics
  • Roxane Laboratories (Boehringer Ingelheim)
  • Shionogi
  • Stallergenes
  • Sun Pharmaceuticals
  • Takeda Pharmaceutical
  • Teva Pharmaceuticals
  • Verona Pharma
  • VentiRx Pharmaceuticals
Market driver
  • Increased prevalence of allergic rhinitis
  • For a full, detailed list, view our report
Market challenge
  • Patent expiries and competition from generic drugs
  • For a full, detailed list, view our report
Market trend
  • Increased R&D
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Allergic Rhinitis Drugs Market 2016-2020Technavio recognizes the following companies as the key players in the Global Allergic Rhinitis Drugs Market: AstraZeneca, GlaxoSmithKline, Meda Pharmaceuticals, Merck, Sanofi and UCB.Other Prominent Vendors in the market are: Adamis Pharmaceuticals, Alcon, Alergo Pharma, ALK-Abello, Allergy Therapeutics, Almirall, Ampio, Anergis, Apotex, Ares Life Sciences, Array BioPharma, Aspen Pharmacare, Atopix Therapeutics, Barr Laboratories, Belcher Pharmaceuticals, Circassia Pharmaceuticals, Dainippon Sumitomo, DBV Technologies, Dr Reddy's Laboratories, Eddingpharm, Genentech, Greer Laboratories, Hanmi Pharmaceuticals, Hisamitsu Pharmaceutical, Intas Pharmaceuticals, Kyowa Hakko, Lupin Pharmaceuticals, Mitsubishi Tanabe Pharma, Mylan, Nektar Therapeutics, Novartis, Nuvo Research, Nycomed, Omega Pharma, Ono Pharmaceuticals, Pfizer, Revance Therapeutics, Roxane Laboratories (Boehringer Ingelheim), Shionogi, Stallergenes, Sun Pharmaceuticals, Takeda, Teva Pharmaceuticals, Verona Pharma, and VentiRx Pharmaceuticals.Commenting on the report, an analyst from Technavio’s team said: “The growing incidence of allergic rhinitis is leading to the demand for advanced and efficient medications. Also, vendors are striving to cater to the unmet medical needs in the market. Drugs such as S-524101, S-555739, and STAGR 320 are in the Phase III stage of development. The launch of these drugs, which have an improved safety and efficacy profile, will drive the growth of the global allergic rhinitis drugs market during the forecast period.”According to the report, the rising prevalence of allergic rhinitis worldwide to play a major role in the growth of the market during the forecast period. Exposure to pollutants in the atmosphere such as vehicular emissions, pollen, or animal dander is a major cause for the rise in the incidence of allergic rhinitis. A decline in the air quality of major cities worldwide is also expect to lead to a rise in the number of people with the condition. An increase in tobacco usage also propels market growth. Further, the report states that patent expiries of major drugs is however, expected to hinder the growth of the market.

Companies Mentioned

AstraZeneca, GlaxoSmithKline, Meda Pharmaceuticals, Merck, Sanofi, UCB, Adamis Pharmaceuticals, Alcon, Alergo Pharma, ALK-Abello, Allergy Therapeutics, Almirall, Ampio, Anergis, Apotex, Ares Life Sciences, Array BioPharma, Aspen Pharmacare, Atopix Therapeutics, Barr Laboratories, Belcher Pharmaceuticals, Circassia Pharmaceuticals, Dainippon Sumitomo, DBV Technologies, Dr Reddy's Laboratories, Eddingpharm, Genentech, Greer Laboratories, Hanmi Pharmaceuticals, Hisamitsu Pharmaceutical, Intas Pharmaceuticals, Kyowa Hakko, Lupin Pharmaceuticals, Mitsubishi Tanabe Pharma, Mylan, Nektar Therapeutics, Novartis, Nuvo Research, Nycomed, Omega Pharma, Ono Pharmaceuticals, Pfizer, Revance Therapeutics, Roxane Laboratories (Boehringer Ingelheim), Shionogi, Stallergenes, Sun Pharmaceuticals, Takeda, Teva Pharmaceuticals, Verona Pharma, VentiRx Pharmaceuticals.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Overview: Allergic rhinitis
    • Understanding the disease
      • Table Types of allergic rhinitis
    • Classification of allergic rhinitis
    • Causes
    • Signs and symptoms
    • Risk factors
      • Table Risk factors associated with allergic rhinitis
    • Diagnosis and testing
      • Table Major diagnostic procedures for allergic rhinitis
      • Table Imaging studies used to diagnose and evaluate allergic rhinitis
    • Treatment
      • Table Summary of pharmacologic treatments for allergic rhinitis
      • Table Non-pharmacological therapies for allergic rhinitis
      • Table Examples of non-pharmacological therapies
      • Table Treatment algorithm of allergic rhinitis
    • Epidemiology
      • Table Prevalence of allergic rhinitis in China
    • Economic burden and impact on quality of life
  • Pipeline analysis
    • Table Global allergic rhinitis drugs market: Pipeline portfolio
    • Information on pipeline candidates
    • Clinical trial information of allergic rhinitis
      • Table Allergic rhinitis clinical trials by development phase 2015
      • Table Allergic rhinitis clinical trials by trial status 2015
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global allergic rhinitis drugs market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation based on class of drugs
    • Table Global allergic rhinitis market based on class of drugs
    • Antihistamines
    • Intranasal corticosteroids
      • Table Examples of prescription and OTC intranasal corticosteroids
    • Immunotherapies
      • Table Global allergic rhinitis drugs market based on class of drugs 2015
      • Table Global allergic rhinitis drugs market based on class of drugs 2015-2020 ($ billions)
    • Global antihistamines drugs market
      • Table Global antihistamines drugs market 2015-2020 ($ billions)
    • Global intranasal corticosteroids drugs market
      • Table Global intranasal corticosteroids drugs market 2015-2020 ($ billions)
    • Global immunotherapies drugs market
      • Table Global immunotherapies drugs market 2015-2020 ($ billions)
  • Market segmentation by route of administration
    • Table Global allergic rhinitis drugs market by route of administration
    • Oral
    • Parenteral
    • Intranasal
  • Market segmentation by dosage form
    • Table Global allergic rhinitis drugs market segmentation by dosage form
    • Solid
    • Liquid
  • Geographical segmentation
    • Global allergic rhinitis drugs market by geography 2015-2020
      • Table Global allergic rhinitis drugs market by geography 2015
      • Table Global allergic rhinitis drugs market revenue by geography 2015-2020 ($ billions)
    • Allergic rhinitis drugs market in Americas
      • Table Allergic rhinitis drugs market in Americas 2015-2020 ($ billions)
    • Allergic rhinitis drugs market in EMEA
      • Table Allergic rhinitis drugs market in EMEA 2015-2020 ($ billions)
    • Allergic rhinitis drugs market in APAC
      • Table Allergic rhinitis drugs market in APAC 2015-2020 ($ millions)
  • Market drivers
    • Table Drivers of global allergic rhinitis drugs market
    • Increased prevalence of allergic rhinitis
    • Rise in awareness about allergic rhinitis
    • High usage of tobacco
    • Presence of high unmet medical needs
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Table Challenges of global allergic rhinitis drugs market
    • Increased preference for CAM
    • Patent expiries and competition from generic drugs
    • Adverse effects of drugs
    • Poor patient adherence
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Table Trends of global allergic rhinitis drugs market
    • Self-medication using OTC products
      • Table Drugs that underwent Rx-to-OTC switch in the US
    • Increased R&D
    • Intense competition
    • Strategic alliances
  • Vendor landscape
    • Competitive scenario
    • Market share analysis 2015
      • Table Global allergic rhinitis drugs market vendor share analysis 2015
      • Table YoY revenue comparison of top drugs for allergic rhinitis 2012-2014 ($ billions)
    • AstraZeneca
      • Table AstraZeneca: Business segmentation by revenue 2014
      • Table AstraZeneca: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table AstraZeneca: Geographical segmentation by revenue 2014
      • Table AstraZeneca: Key takeaways
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Business segmentation by revenue 2014
      • Table GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table GlaxoSmithKline: Geographical segmentation by revenue 2014
      • Table GlaxoSmithKline: YoY growth and revenue of Avamys/Veramyst 2012-2014 ($ millions)
      • Table GlaxoSmithKline: Key takeaways
    • Meda Pharmaceuticals
      • Table Meda Pharmaceuticals: Product segmentation by revenue 2014
      • Table Meda Pharmaceuticals: Product segmentation by revenue 2013 and 2014 ($ millions)
      • Table Meda Pharmaceuticals: Geographical segmentation by revenue 2014
      • Table Meda Pharmaceuticals: Top-selling drugs
      • Table Meda Pharmaceuticals: YoY growth and revenue of Dymista 2012-2014 ($ millions)
      • Table Meda Pharmaceuticals: YoY growth and revenue of EpiPen 2012-2014 ($ millions)
      • Table Meda Pharmaceuticals: Key takeaways
    • Merck
      • Table Merck: Business segmentation by revenue 2014
      • Table Merck: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Merck: Geographical segmentation by revenue 2014
      • Table Merck: Top-selling drugs
      • Table Merck: YoY growth and revenue of Nasonex 2012-2014 ($ billions)
      • Table Merck: YoY growth and revenue of Singulair 2012-2014 ($ billions)
      • Table Merck: YoY growth and revenue of Clarinex 2012-2014 ($ millions)
      • Table Merck: Key takeaways
    • Sanofi
      • Table Sanofi: Business segmentation by revenue 2014
      • Table Sanofi: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Sanofi: Geographical segmentation by revenue 2014
      • Table Sanofi: Top-selling drugs
      • Table Sanofi: YoY growth and revenue of Allegra 2012-2014 ($ millions)
      • Table Sanofi: YoY growth and revenue of Allegra OTC 2012-2014 ($ millions)
      • Table Sanofi: YoY revenue comparison of Nasacort ($ millions)
      • Table Sanofi: Key takeaways
    • UCB
      • Table UCB: Product segmentation by revenue 2014
      • Table UCB: Product segmentation by revenue 2013 and 2014 ($ billions)
      • Table UCB: Geographical segmentation by revenue 2014
      • Table UCB: YoY growth and revenue of Zyrtec 2012-2014 ($ millions)
      • Table UCB: YoY growth and revenue of Xyzal 2012-2014 ($ millions)
      • Table UCB: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report